# GLATIRAMER ACETATE
> **ANDA203857** · Abbreviated New Drug Application (Generic) · Sponsor: SYNTHON PHARMS INC · Approved 2024-09-25
## Drug
- **FDA Application Number:** ANDA203857
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GLATIRAMER ACETATE
- **Generic name:** GLATIRAMER ACETATE
- **Active ingredients:** GLATIRAMER ACETATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SYNTHON PHARMS INC
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2024-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203857)
---
*MORVS · CC0 1.0*